Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti–vascular endothelial growth factor therapy of macular diseases
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1435-702X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti–vascular endothelial growth factor therapy of macular diseases ; day:19 ; month:5 ; year:2017 ; pages:1-15
Graefe's archive for clinical and experimental ophthalmology ; (19.5.2017), 1-15
- Keyword
-
Augenheilkunde
Augenkrankheit
- Contributor
-
Lanzetta, Paolo
Loewenstein, Anat
SpringerLink (Online service)
- DOI
-
10.1007/s00417-017-3647-4
- URN
-
urn:nbn:de:1111-2017052810985
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lanzetta, Paolo
- Loewenstein, Anat
- SpringerLink (Online service)
Other Objects (12)
Intravitreal injection with anti-vascular endothelial growth factor (anti-VEGF) in diabetic macular edema (DME) versus vitrectomy with internal limiting membrane (ILM) peeling with anti-VEGF as an adjuvant
Non-adherence and non-persistence to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy: a systematic review and meta-analysis
Case report: heart failure related to intravitreal injection of anti-VEGF
Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor
Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
Estimation of the need for bilateral intravitreal anti-VEGF injections in clinical practice
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic
Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case Series
Investigation of choroidal structure changes after intravitreal anti-VEGF therapy for retinal vein occlusion
Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Intravitreal injection with anti-vascular endothelial growth factor (anti-VEGF) in diabetic macular edema (DME) versus vitrectomy with internal limiting membrane (ILM) peeling with anti-VEGF as an adjuvant
Non-adherence and non-persistence to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy: a systematic review and meta-analysis
Case report: heart failure related to intravitreal injection of anti-VEGF
Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor
Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
Estimation of the need for bilateral intravitreal anti-VEGF injections in clinical practice
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic
Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case Series
Investigation of choroidal structure changes after intravitreal anti-VEGF therapy for retinal vein occlusion
Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Intravitreal injection with anti-vascular endothelial growth factor (anti-VEGF) in diabetic macular edema (DME) versus vitrectomy with internal limiting membrane (ILM) peeling with anti-VEGF as an adjuvant
Non-adherence and non-persistence to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy: a systematic review and meta-analysis
Case report: heart failure related to intravitreal injection of anti-VEGF
Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor
Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
Estimation of the need for bilateral intravitreal anti-VEGF injections in clinical practice
Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic
Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
Hydrophilic Lens Opacification after Intravitreal Anti-VEGF Injections: A Case Series
Investigation of choroidal structure changes after intravitreal anti-VEGF therapy for retinal vein occlusion
Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics